Concepedia
Statistics
Publications
12
Citations
2.4K
H-Index
Active since
2002
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (Sweden)
AstraZeneca (France)
Alison Bigley is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and oncology.
Publications per year
2002–2016
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
Stephen R. Wedge, Donald Ogilvie, Michael Dukes et al. · PubMed · 2002 · 802 citations
Medicine, Medicinal Chemistry, Pharmacology +15
AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
Stephen R. Wedge, Jane Kendrew, Laurent Hennequin et al. · Cancer Research · 2005 · 711 citations · Full text
Medicine, Oncology, Pharmacology +17
AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis
Robert W. Wilkinson, Rajesh Odedra, Simon P. Heaton et al. · Clinical Cancer Research · 2007 · 357 citations · Full text
Medicine, Oncology, Pharmacology +16
Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity
F. Russell Westwood, Alison Bigley, Kevin J. Randall et al. · Toxicologic Pathology · 2005 · 212 citations
Medicine, Physiology, Toxicology +15
Tissue-specific Expression and Subcellular Distribution of Murine Glutathione S-transferase Class Kappa
Rachel E. Thomson, Alison Bigley, John R. Foster et al. · Journal of Histochemistry & Cytochemistry · 2004 · 71 citations
Life Sciences, Biochemistry, Molecular Biology +14
1–5 of 12